# Drug Drug Interaction (DDI) Between Supaglutide and Digoxin or Metformin

> **NCT05694221** · PHASE1 · COMPLETED · sponsor: **Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.** · enrollment: 34 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Supaglutide injection
- **DRUG:** Digoxin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05694221
- **Lead sponsor:** Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-20
- **Primary completion:** 2023-06-06
- **Final completion:** 2023-08-17
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2024-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05694221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05694221, "Drug Drug Interaction (DDI) Between Supaglutide and Digoxin or Metformin". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05694221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*